Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
26 Patents
#103 in Cambridge, MA
#775 in Massachusetts
#12,865 in US
#24,826 in the World
Foghorn Therapeutics Inc.
Forward Citations = 66
30 inventors:
Cambridge, MA, United States of America
Foghorn Therapeutics Inc.
EPO Patents = 5
Trademarks = 3
Forward Citations = 66
Loading Chart...
Loading Chart...
30 inventors (with patents filed for the assignee):
Sabine K Ruppel (12 out of 14 patents)
Jason T Lowe (11 out of 14 patents)
Zhaoxia Yang (11 out of 11 patents)
4. Johannes H Voigt (11 out of 13 patents)
5. Rishi G Vaswani (10 out of 28 patents)
6. Shawn E R Schiller (6 out of 30 patents)
7. Neville J Anthony (6 out of 73 patents)
8. David Simon Millan (6 out of 6 patents)
9. Francois Brucelle (6 out of 6 patents)
10. Matthew Netherton (6 out of 6 patents)
11. David S Huang (5 out of 6 patents)
12. Kevin J Wilson (5 out of 6 patents)
13. Matthew Russell Netherton (4 out of 4 patents)
14. Shawn ER Schiller (3 out of 3 patents)
15. Chong-Hui Gu (2 out of 21 patents)
Core Competencies:
BRM Inhibitors
BRG1 Inhibitors
BAF Complex
Cancers
Degraders
Pharmaceutical Compositions
Citrate Salt
Compounds
Treating Disorders
Crystalline Forms
Methods of Use
26 patents:
Company Overview
Foghorn Therapeutics Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapies for cancer and other serious diseases. The company leverages its proprietary Gene Traffic Control platform to discover and develop treatments that target gene regulation mechanisms. Foghorn's research focuses on advancing understanding of epigenetics and its role in disease, aiming to create transformative therapies that address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Foghorn Therapeutics Inc.. Retrieved from https://idiyas.com/company/foghorn-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]